5-MeO-DMT
Angelica Ukaigwe, Abhishek Chauhan, S. Vinod Kumar
May 1, 2025 DOI: 10.1093/med/9780197760864.003.0007 via OpenAlex
Summary
AI-generated from the abstract5-MeO-DMT is a psychoactive compound from the Sonoran Desert toad's venom and certain plants, now used as a spiritual sacrament in some churches. It may help process anxiety, depression, PTSD, drug use disorder, and existential crisis, and shows promise in palliative care for improving quality of life and end-of-life attitudes. Side effects include adrenergic responses and a reactivation phenomenon where drug-induced experiences recur weeks to months later. Synthetic forms enable standardized dosing. Legal status is unclear; it could be illegal as a DMT derivative under U.S. law, with possible religious exemptions. Demand threatens the toad population, making synthetic production imperative.
Study at a glance
| Characteristics | Review |
|---|---|
| Keywords | Computer science |
| Key finding | 5-MeO-DMT shows therapeutic potential for anxiety, depression, PTSD, drug use disorder, and existential crisis, but demand threatens the Sonoran Desert toad, making synthetic production imperative. |
Abstract
Abstract 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychoactive compound found in the parotid gland venom of the Sonoran Desert toad, Incilius alvarius, and certain seeds, leaves, and barks within the Amazonian rainforest. Similar to DMT containing ayahuasca, 5-MeO-DMT has become newly integrated as a spiritual sacrament in certain churches, offering a psychedelic experience to process feelings and symptoms associated with anxiety, depression, post-traumatic stress disorder, drug use disorder, and existential crisis. Its ability to improve quality of life and/or attitudes toward end of life has garnered interest from the field of palliative care. Its potential to assist individuals with processing life-changing diagnoses supports further research on its therapeutic scope. Side effects include adrenergic responses and “reactivation phenomenon,” in which the individual re-experiences moments of the drug-induced state weeks to months post administration. The synthetic form of the venom offers the opportunity for standardized production and dosing while still maintaining its therapeutic potential. 5-MeO-DMT’s legal status has not been specifically addressed by U.S. nor European laws, but if likened to a derivative of DMT, it would be illegal under U.S. law, with possible religious exemptions and potential for decriminalization. Although not yet listed as a “threatened species,” there is concern that with demand for 5-MeO-DMT, the toad population and the ecological equilibrium will become disrupted. Most important, the creation of synthetic 5-MeO-DMT to combat extinction of the Sonoran Desert toad remains imperative.